African Trainings, Events, & Conferences
In each region, the Global Campaign follows leads of our local partners and endorsers, so that the strategies are appropriate to the context, interest, and capacity of our partner organisations. GCM supports these groups through a combination of site visits, technical assistance, ongoing communications, information resources, skills building workshops and regional strategy meetings.
|30 - 31 August 2011: 2nd South African Women’s HIV Prevention Summit|
The SANAC Women’s sector through The Global Campaign for Microbicides (GCM), Department of Science and Technology (DST), International Aids Vaccine Initiative (IAVI) and the International Partnership for Microbicides (IPM) will be hosting the 2nd South African Women’sHIV Prevention Summit. The meeting will focus on women’s needs, interventions and progress made in HIV Prevention.
|31 August - 1 September 2010: Kenya Women's HIV Prevention Symposium|
The Global Campaign and the National AIDS Control Council co-hosted the First Kenya Women's HIV Prevention Symposium on 31 August and 1 September in Nairobi. Sponsors included KANCO, Liverpool VCT, Action Aid Kenya, GTZ, CHIVPR, and the UN team. The first women's HIV prevention champion was announced at the event. (more)
|25 - 26 August 2010: WHO/UNAIDS Consensus Meeting on Tenofovir Gel|
GCM Director Yasmin Halima and Africa Programme Leader Samu Dube attended and expert consultation exploring the implications of the CAPRISA 004 trial on 25 and 26 August 2010. Sponored by USAID, WHO, and the Republic of South Africa's Department of Science and Technology, the meeting breings together representatitves from government, industry, research, and advocacy organizations and to assess the situation and determine next steps for research and continued progress in the biomedical HIV-prevention product field.
Accordign to the USAID, the purpose of the meeting is to reach consensus and plan the next steps in the development of 1% tenofovir gel following the release of the CAPRISA 004 trial results.
The specific objects are to:
- Identify gaps in, and develop consensus on, priority research to confirm safely, effectiveness, and acceptability of 1% tenofovir gel;
- Develop the most efficient pathways for licensure and guideline development, including regulatory dossier development and submission;
- Delineate priorities, next steps and lead responsibilities in clinical research, programmatic research, and regulatory submission, and other issues as identified; and
- Agree on mechanisms for coordination, execution, and identification of funding sources and gaps.
|5 - 6 July 2010: Prevention and People Living with HIV: GNP+ consultation|
Samu Dube represented GCM at an international consultation hosted by GNP+ on the implications of new prevention tools for people living with HIV.
|30 June 2010: SAfAIDS Capacity Building Workshop|
Samu Dube was invited to present at the Southern African HIV and AIDS Information Dissemination Service (SAfAIDS) regional capacity-development workshop on 30 June in Pretoria. Discussing user-controlled HIV-prevention technologies for sub-Saharan Africa, she helped train trainers to integrate information about prevention into gender equality programmes.
|28 - 29 June 2010: Prevention Literacy Training, South Africa|
GCM facilitated a prevention-research-literacy training in Venda, attended by 30 staff members from Thoyandou Victim Empowerment Programme.
|27 June 2010: Improving Trial Communications and Media Coverage|
GCM’s Deborah Baron, who coordinates the MMCI and mentors the GCM fellows, worked with fellow Munyaradzi Chimwara to conduct a media and communications training with researchers and trial staff from the Microbicides Trial Network, International Programme for Microbicides, and other research networks on 28 June in Harare, Zimbabwe.
Aside from a few media savvy veterans, most of the participants had minimal or no experience nor training in working with the media. One medical officer noted, “I don’t like talking to media because they don’t include what I tell them about my study anyway.”
After spending a day learning tips and techniques on how to explain prevention research and his study more clearly, he realized that working with the media is a two-way street, and he now feels more equipped to meet them halfway.
The following day, the facilitators hosted a journalists’ training with local print, radio, and TV journalists. Following sessions on the HIV life cycle and a talk on the ethics of research with a representative from the Medical Research Council, Baron and Chimwara led a discussion on the common challenges that journalists face. They offered creative ways to keep readers interested in HIV prevention, despite the infrequency of significant news to report.
“This will be the first training we’ve done since the launch of the Communications Handbook at Microbicides 2010. We’re really excited to incorporate the tools and lessons learned from this new resource into a hands-on training with those working on the front lines of HIV prevention research,” said Baron, who also serves as Chimwara’s mentor in the fellowship program.
Chimwara’s fellowship project addresses how the media reports on and is engaged in HIV-prevention trials in Zimbabwe. He is identifying needs and opportunities—such as conducting these trainings—to improve the media’s ongoing balanced, accurate, consistent and reliable reporting on HIV-prevention trials in Zimbabwe.
Country coordinator Pauline Irungu led a community dialogue in Mombasa on 3 June and a site visit for members of civil society on 4 June.
8-9 June. GCM conducted a skills-building workshop for civil society members from Rift Valley province in Nakuru.
16-17 June. GCM conducted a Prevention Research Literacy Training workshop in Nairobi, which drew participants from Nairobi, Thika, Coast, and Nyanza provinces, areas where HIV-prevention research is taking place.
24 June. In collaboration with Internews Network, the USAID-funded media NGO, GCM hosted a media roundtable in Nairobi. We sought to raise awareness among journalists about new HIV-prevention products under development and to strengthen GCM’s media relationships.
GCM conducted a site visit for journalists at the PiP PrEP Thika clinical trial site on 30 June. The aim of this visit was to provide journalists with an opportunity to gain better understanding of how clinical trial sites operate, to interact with community members and site staff, and to establish rapport to improve reporting for HIV-prevention research in Kenya.